Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Agilent (A)
NYSE:A
Holding A?
Track your performance easily
A Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$123.48 - $155.35
Previous Close$128.57
Volume326.27K
Average Volume (3M)1.59M
Market Cap
$36.69B
Enterprise Value$37.36B
Total Cash (Recent Filing)$1.78B
Total Debt (Recent Filing)$2.93B
Price to Earnings (P/E)26.0
Beta1.04
Next Earnings
Nov 25, 2024EPS Estimate
$1.41Last Dividend Ex-Date
Oct 01, 2024Dividend Yield0.75%
Share Statistics
EPS (TTM)4.83
Shares Outstanding287,327,671
10 Day Avg. Volume2,167,711
30 Day Avg. Volume1,590,190
Standard Deviation0.08
R-Squared0.51
Alpha-0.00015
Financial Highlights & Ratios
Price to Book (P/B)6.26
Price to Sales (P/S)5.56
Price to Cash Flow (P/CF)20.00
P/FCF Ratio23.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.76
Enterprise Value/Gross Profit10.78
Enterprise Value/Ebitda23.36
Forecast
1Y Price Target
$154.75Price Target Upside18.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Agilent News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAgilent's EPS of $1.32 beat expectations by 5%, showing strong financial performance.
Market Position And GrowthA's global scale, industry-leading market shares, massive installed base, innovative culture, scale in services, and software/digital capabilities are key competitive advantages that should enable it to drive above-market growth over time.
Strategic AcquisitionThe BioVectra acquisition will expand its CDMO services offering in higher-growth segments and enable a more complete gene editing solution.
Bears Say
Financial PerformanceThe proposed deal would boost core growth by ~25 bps but be ~$0.05 dilutive year-one, intensify competition (directly with DHR) and double down on specialized CDMO even as investors remain skeptical on NASD growth.
Market DemandA discussed an already tepid Biopharma customer weakening further along with broad based demand slowing in China.
ValuationValuation appears fair given higher China exposure and limited visibility into a market rebound.
---
Ownership Overview
0.35% Insiders
31.41% Mutual Funds
20.64% Other Institutional Investors
22.12% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
A FAQ
What was Agilent’s price range in the past 12 months?
Agilent lowest stock price was $123.48 and its highest was $155.35 in the past 12 months.
What is Agilent’s market cap?
Currently, no data Available
When is Agilent’s upcoming earnings report date?
Agilent’s upcoming earnings report date is Nov 25, 2024 which is in 4 days.
How were Agilent’s earnings last quarter?
Agilent released its earnings results on Aug 21, 2024. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.259 by $0.061.
Is Agilent overvalued?
According to Wall Street analysts Agilent’s price is currently Undervalued.
Does Agilent pay dividends?
Agilent pays a Quarterly dividend of $0.24 which represents an annual dividend yield of 0.75%. See more information on Agilent dividends here
What is Agilent’s EPS estimate?
Agilent’s EPS estimate is $1.41.
How many shares outstanding does Agilent have?
Agilent has 287,327,670 shares outstanding.
What happened to Agilent’s price movement after its last earnings report?
Agilent reported an EPS of $1.32 in its last earnings report, beating expectations of $1.259. Following the earnings report the stock price went up 0.165%.
Which hedge fund is a major shareholder of Agilent?
Among the largest hedge funds holding Agilent’s share is Generation Investment Management LLP. It holds Agilent’s shares valued at 451M.
---
Agilent Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$154.75 (18.46% Upside)
$154.75 (18.46% Upside)
Blogger Sentiment
Bullish
A Sentiment 91%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 2.9M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.0%
Last 30 Days ▲ 2.1%
Last 30 Days ▲ 2.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
13.56%
12-Months-Change
Fundamentals
Return on Equity
24.66%
Trailing 12-Months
Asset Growth
3.01%
Trailing 12-Months
Company Description
Agilent
Agilent Technologies, Inc. is an analytical instrumentation development and manufacturing company. The company provides instruments, software, services, consumables, and expertise to address the full range of scientific and laboratory management needs.
---
A Company Deck
---
A Earnings Call
Q3 2024
0:00 / 0:00
---
A Revenue Breakdown
56.43% Life Sciences and Applied Markets
22.95% Agilent CrossLab
20.62% Diagnostics and genomics
---
A Stock 12 Month Forecast
Average Price Target
$154.75
▲(18.46% Upside)
Technical Analysis
Best Analysts Covering A
1 Year
1 Year Success Rate
26/32 ratings generated profit
1 Year Average Return
+20.70%
initiated a buy rating 3 months ago
Copying Brandon Couillard's trades and holding each position for 1 Year would result in 81.25% of your transactions generating a profit, with an average return of +20.70% per trade.
---